NCT04693364

Brief Summary

This study is to find out the acceptability of a 3D printed breast model by patients as they consider their surgical treatment options. Researchers also want to learn the possible impact of the 3D printed breast model in the patient's decision making process.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 27, 2017

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2022

Completed
Last Updated

March 8, 2022

Status Verified

March 1, 2022

Enrollment Period

4.2 years

First QC Date

December 28, 2020

Last Update Submit

March 4, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in patient decisional conflict

    Will be assessed based on changes in decisional conflict scale data collected before and after use of the 3 dimensional (3D) printed breast model during consultation with the breast surgeon using paired sample t-tests.

    45 minutes - up to 12 months

  • Acceptability of the 3D model

    Will be measured with questions adapted from the Ottawa measures. 'Acceptability' (of a decision aid) refers to ratings regarding the comprehensibility of components of a decision aid, its length, pace (if audio-visual), amount of information, balance in presentation of information about options, and overall suitability for decision making. Responses are reported descriptively in terms of the proportions of patients responding positively or negatively on each criterion.

    45 minutes - up to 12 months

Study Arms (1)

Observational (questionnaire, 3D breast model, discussion)

Patients complete questionnaire over 5 minutes about difficulties in making decision about breast cancer treatment, then participate in a consultation with regular care doctor and study doctor/study staff using the 3D breast model. Patients then complete questionnaires over 5-10 minutes about their opinions on the breast model and different breast surgical treatment options available.

Other: Decision AidProcedure: DiscussionOther: Questionnaire Administration

Interventions

Use 3D printed breast model

Observational (questionnaire, 3D breast model, discussion)
DiscussionPROCEDURE

Participate in consultation

Also known as: Discuss
Observational (questionnaire, 3D breast model, discussion)

Complete questionnaires

Observational (questionnaire, 3D breast model, discussion)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with breast cancer who are candidates for surgical management and agreed to have a 3D model created

You may qualify if:

  • Age 18 or older
  • Women diagnosed with breast cancer
  • Patient is a candidate for surgical management
  • Patient has a surgeon at MD Anderson Cancer Center (MDACC) (main campus and/or regional care centers) who has agreed to have the 3D model created
  • Patients with a breast magnetic resonance imaging (MRI) performed at the MD Anderson (at the West Houston location as well as main campus)
  • Patient able to speak, read or write English
  • PHYSICIAN ELIGIBILITY: Breast surgeon

You may not qualify if:

  • Pregnant and breast feeding patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Decision Support Techniques

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Elsa Arribas

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2020

First Posted

January 5, 2021

Study Start

December 27, 2017

Primary Completion

February 22, 2022

Study Completion

February 22, 2022

Last Updated

March 8, 2022

Record last verified: 2022-03

Locations